Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood (Q33494589)

27 July 2017

title

Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood (English)

1 reference

hemolytic-uremic syndrome

27 July 2017

0 references

1 reference

5

Barratt TM

1 reference

27 July 2017

Fitzpatrick MM

1

1 reference

27 July 2017

Walters MD

series ordinal

2

1 reference

27 July 2017

Trompeter RS

series ordinal

3

1 reference

27 July 2017

Dillon MJ

series ordinal

4

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 April 1993

1 reference

The Journal of Pediatrics

27 July 2017

published in

1 reference

27 July 2017

volume

122

1 reference

27 July 2017

issue

4

1 reference

27 July 2017

page(s)

532-537

1 reference

Hemolytic Uremic Syndrome in Families

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

The hemolytic-uremic syndrome: spectrum of severity and significance of prodrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Haemolytic-uraemic syndrome: an analysis of prognostic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Haemolytic uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Platelet-derived growth factors as possible mediators of vascular proliferation in the sporadic haemolytic uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

HUS and TTP: variable expression of a single entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Intravascular platelet activation in the hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Thomsen-Friedenreich antigen in haemolytic-uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Hemolytic-uremic syndrome associated with pneumococcal sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Hemolytic-uremic syndrome and T-cryptantigen exposure by neuraminidase-producing pneumococci: an emerging problem?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Measurement of plasma renin activity by semi-micro radioimmunoassay of generated angiotensin I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Long term renal outcome of childhood haemolytic uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Endotheliotropic (hemolytic) nephroangiopathy and its various manifestation forms (thrombotic microangiopathy, primary malignant nephrosclerosis, hemolytic-uremic syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Apparent recurrence of hemolytic uremic syndrome in azathioprine-treated allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Recurrent haemolytic uraemic syndrome in a transplant recipient on orthoclone (OKT 3)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Selective thrombocytopenia due to localised microangiopathy of renal allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Microangiopathic hemolytic anemia in renal allotransplantation. Repart of a successfully treated case and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983531-0

10.1016/S0022-3476(05)83531-0

7 January 2021

Identifiers

DOI

1 reference

27 July 2017

1 reference